Rick Bright, the ousted chief of the Biomedical Advanced Research and Development Agency, said he was pressured to steer millions of dollars to the clients of a well-connected consultant.

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting ...

New York State’s stockpile of antiviral medications for flu contains only one drug, Tamiflu, leaving no fallback plan. By Joseph Goldstein A big boost for the military, more aid for Ukraine, a ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

Caption] Sabin Vaccine Institute delivered 700 doses of its Marburg vaccine to Rwanda on Oct. 5, 2024.WASHINGTON, Oct. 05, ...

The BARDA funding will support studies to validate the Melbourne, Australia-headquartered firm's flagship FebriDx rapid host-response respiratory infection test in low complexity settings and ...

Ossium Health, a commercial-stage bioengineering company with the first-of-its-kind bone marrow bank for processing and deploying stem cell-based therapies, today announced the signing of a contract ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

The firm will enter studies this month aimed at obtaining CLIA waiver for its FDA-cleared FebriDx assay to distinguish bacterial from non-bacterial infections.

Available cash €5.95 million, up from €2.3 million on December 31, 2023Reports stable investments in R&D and consolidation of operating ...

earning the chance to pocket up to $135 million over six years from the Biomedical Advanced Research and Development Authority (BARDA), an office of the Department of Health and Human Services ...